BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31153393)

  • 1. Monte carlo study of organ doses and related risk for cancer in Tanzania from scattered photons in cervical radiation treatment involving Co-60 source.
    Suleiman SA; Qi Y; Chen Z; Xu XG
    Phys Med; 2019 Jun; 62():13-19. PubMed ID: 31153393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MONTE CARLO SIMULATION OF OUT-OF-FIELD ORGAN DOSES AND CANCER RISK IN TANZANIA FOR RADIATION THERAPY OF UNILATERAL RETINOBLASTOMA USING A 60Co UNIT.
    Suleiman SA; Qi Y; Pi Y; George Xu X
    Radiat Prot Dosimetry; 2018 May; 179(3):263-270. PubMed ID: 29216393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study.
    Lee B; Ahn SH; Kim H; Son J; Sung J; Han Y; Huh SJ; Kim JS; Kim DW; Yoon M
    J Appl Clin Med Phys; 2016 Sep; 17(5):124-132. PubMed ID: 27685104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second primary malignancies after radiotherapy including HDR (252)Cf brachytherapy for cervical cancer.
    Samerdokiene V; Valuckas KP; Janulionis E; Atkocius V; Rivard MJ
    Brachytherapy; 2015; 14(6):898-904. PubMed ID: 26194049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT.
    Alem-Bezoubiri A; Suleiman SA; Behidj I; Mazrou H; Chami AC
    Appl Radiat Isot; 2022 Feb; 180():110065. PubMed ID: 34933226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculated organ doses using Monte Carlo simulations in a reference male phantom undergoing HDR brachytherapy applied to localized prostate carcinoma.
    Candela-Juan C; Perez-Calatayud J; Ballester F; Rivard MJ
    Med Phys; 2013 Mar; 40(3):033901. PubMed ID: 23464344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric optimization of a colpostat in a 60Co high-dose-rate brachytherapy unit for bladder sparing.
    Zakariaee SS; Mahdavi SR
    Brachytherapy; 2015; 14(1):37-45. PubMed ID: 25260688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with
    Safigholi H; Han DY; Mashouf S; Soliman A; Meigooni AS; Owrangi A; Song WY
    Med Phys; 2017 Dec; 44(12):6538-6547. PubMed ID: 28940520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
    Nesseler JP; Charra-Brunaud C; Salleron J; Py JF; Huertas A; Meknaci E; Courrech F; Peiffert D; Renard-Oldrini S
    Brachytherapy; 2017; 16(5):976-980. PubMed ID: 28694116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of organs doses and radiation-induced secondary cancer risk from scattered photons for conventional radiation therapy of nasopharynx: a Monte Carlo study.
    Mesbahi A; Seyednejad F; Gasemi-Jangjoo A
    Jpn J Radiol; 2010 Jun; 28(5):398-403. PubMed ID: 20585932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results for Stage IIIB cervical cancer patients receiving external beam radiotherapy combined with either HDR (252)Cf or HDR (60)Co intracavitary brachytherapy.
    Ulinskas K; Janulionis E; Valuckas KP; Samerdokiene V; Atkocius V; Rivard MJ
    Brachytherapy; 2016; 15(3):353-360. PubMed ID: 26996594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of developing radiogenic cancer following photon-beam radiotherapy for Graves' orbitopathy.
    Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
    Med Phys; 2018 Oct; 45(10):4775-4782. PubMed ID: 30105825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of planned and measured rectal dose in-vivo during high dose rate Cobalt-60 brachytherapy of cervical cancer.
    Zaman ZK; Ung NM; Malik RA; Ho GF; Phua VC; Jamalludin Z; Baharuldin MT; Ng KH
    Phys Med; 2014 Dec; 30(8):980-4. PubMed ID: 25086486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens.
    Mayer A; Nemeskéri C; Petneházi C; Borgulya G; Varga S; Naszály A
    Strahlenther Onkol; 2004 Apr; 180(4):209-15. PubMed ID: 15057431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer.
    Murray L; Mason J; Henry AM; Hoskin P; Siebert FA; Venselaar J; Bownes P;
    Radiother Oncol; 2016 Aug; 120(2):293-9. PubMed ID: 27370205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation dose and cancer risk to out-of-field and partially in-field organs from radiotherapy for symptomatic vertebral hemangiomas.
    Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
    Med Phys; 2016 Apr; 43(4):1841. PubMed ID: 27036581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
    Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doses to internal organs for various breast radiation techniques--implications on the risk of secondary cancers and cardiomyopathy.
    Pignol JP; Keller BM; Ravi A
    Radiat Oncol; 2011 Jan; 6():5. PubMed ID: 21235766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.